Author:
McGregor Iain S,Clemens Kelly J,Van der Plasse Geoffrey,Li Kong M,Hunt Glenn E,Chen Feng,Lawrence Andrew J
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference82 articles.
1. Aguirre N, Ballaz S, Lasheras B, Delrio J (1998). MDMA (Ecstasy) enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia—blockade by drugs preventing 5-hydroxytryptamine depletion. Eur J Pharmacol 346: 181–188.
2. Aguirre N, Galbete JL, Lasheras B, Delrio J (1995). Methylenedioxymethamphetamine induces opposite changes in central pre- and postsynaptic 5-HT1A receptors in rats. Eur J Pharmacol 281: 101–105.
3. Bankson MG, Cunningham KA (2002). Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT1B/1D and 5-HT2 receptors. Neuropsychopharmacology 26: 40–52.
4. Battaglia G, Sharkey J, Kuhar MJ, De Souza EB (1991). Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography. Synapse 8: 249–260.
5. Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB (1987). 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3 h]paroxetine-labeled serotonin uptake sites. J Pharmacol Exp Ther 242: 911–916.
Cited by
95 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献